Online citations, reference lists, and bibliographies.
← Back to Search
DOI: 10.1007/s11065-018-9369-5

A Meta-analysis Of The Effects Of Antidepressants On Cognitive Functioning In Depressed And Non-depressed Samples

Catherine E. Prado, Stephanie Watt, S. Crowe
Published 2018 · Psychology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
A thorough understanding of the cognitive effects of antidepressant medications is essential given their frequency of use. This meta-analysis was conducted to investigate whether antidepressants differentially affect the various domains of cognitive functioning for depressed and non-depressed participants. An electronic search of PsycInfo, Medline and Google Scholar was conducted for all journal articles published between January 1998 and January 2017. Thirty-three studies were included enabling calculation of Hedges’ g using a random effects model for the cognitive domains of divided attention, executive function, expressive language, immediate memory, perceptual motor skills, processing speed, recent memory, sustained attention, visuospatial-constructional skills and working memory. Results revealed that overall, antidepressants have a modest, positive effect on divided attention, executive function, immediate memory, processing speed, recent memory and sustained attention for depressed participants. Selective serotonin reuptake inhibitors (SSRI’s) were found to have the greatest positive effect on cognition for depressed participants, as compared to the other classes of antidepressants analysed. Antidepressants did not significantly affect cognitive function in non-depressed participants.
This paper references
10.2307/2529115
Statistical Power Analysis for the Behavioral Sciences
J. Cohen (1969)
10.1097/01.psyphr.0000422136.00732.93
Monoamine oxidase inhibitors.
M. Dent (1970)
10.1212/WNL.24.11.1019
Evaluating storage, retention, and retrieval in disordered memory and learning
H. Buschke (1974)
Evaluation of storage , retention and retrieval in disordered memory and learning
M. A. Butters (1974)
10.1016/0028-3932(89)90128-0
Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: Evidence for a specific attentional dysfunction
J. Downes (1989)
Impaired extra-dimensional shift
T. W. Robbins (1989)
10.5860/choice.29-2400
A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary
O. Spreen (1991)
10.1016/0895-4356(92)90054-Q
Variance imputation for overviews of clinical trials with continuous response.
D. Follmann (1992)
Antidépresseurs et mémoire. Discussion
J. Danion (1993)
Antidepressive agents and memory
Danion Jm (1993)
10.1016/0028-3932(93)90147-R
Investigations of the functional anatomy of attention using the stroop test
C. Bench (1993)
10.1080/01688639408402697
Tower of London procedure: a standard method and developmental data.
R. O. Krikorian (1994)
10.2165/00002512-199405030-00005
Effects of Antidepressants on Cognitive Functioning of Elderly Patients
H. Knegtering (1994)
10.1016/0028-3932(94)00098-A
Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man
A. Owen (1995)
10.1037//0894-4105.9.2.255
Speech and language in high-functioning autistic individuals.
N. Minshew (1995)
10.3109/09638289509166638
The Purdue Pegboard Test: normative data for people aged 60 and over.
J. Desrosiers (1995)
10.1016/0149-7634(94)00068-C
Effects of antidepressants on cognitive functions: A review
I. Amado-Boccara (1995)
10.2165/00002018-199614040-00002
Monoamine Oxidase Inhibitors
M. Livingston (1996)
Antidepressants and cognitive impairment in the elderly.
Oxman Te (1996)
Antidepressants and cognitive impairment in the elderly.
T. Oxman (1996)
10.1016/0165-0327(96)00027-4
Executive dysfunction in depression: the Wisconsin Card Sorting Test.
S. Channon (1996)
10.1097/00005053-199712000-00005
Cognitive impairment in the euthymic phase of chronic unipolar depression.
S. Paradiso (1997)
10.1016/S0887-6177(96)00003-0
Subscale validity of the Mattis Dementia Rating Scale.
D. Marson (1997)
10.1016/S0140-6736(05)63832-9
Meta-analysis of randomised controlled trials
P. Rothwell (1997)
10.1177/026988119701100204
Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression
G. Goodwin (1997)
10.1016/S0140-6736(97)08468-7
Summing up evidence: one answer is not always enough
J. Lau (1998)
10.1056/JP199802010000003
Cognitive Deficits in Depression and Alzheimer's Disease
G. Tucker (1998)
10.1016/S0165-0327(98)00222-5
Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
W. D. Horst (1998)
10.1016/S0887-6177(97)00027-9
A review of the neuropsychological effects of commonly used prescription medications.
R. Stein (1998)
10.1076/CLIN.12.1.43.1726
Hopkins Verbal Learning Test—Revised: Normative data and analysis of inter-form and test–retest reliability.
R. H. Benedict (1998)
RBANS Manual: Repeatable battery for the assess
technical (1998)
The Category Specific Names Test. Levittown
P. McKenna (1998)
Mechanisms of action and clin
S. H. Preskorn (1998)
10.1146/ANNUREV.NEURO.22.1.197
Monoamine oxidase: from genes to behavior.
J. C. Shih (1999)
The Rivermead Behavioural Memory Test - Extended Version
B. Wilson (1999)
10.1097/00019442-199908000-00006
Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression.
S. Finkel (1999)
10.1017/S0033291798008010
Anxiety, depression, psychotropic drug use and cognitive impairment.
S. Paterniti (1999)
Rey Auditory-Verbal Learning Test
M. N. Mitruchina (1999)
Monoamine oxidase: from genes
J. 70193-3. Shih (1999)
10.1177/026988110001400101
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines
I. Anderson (2000)
10.1006/cogp.1999.0734
The Unity and Diversity of Executive Functions and Their Contributions to Complex “Frontal Lobe” Tasks: A Latent Variable Analysis
A. Miyake (2000)
10.1016/S0006-3223(00)00910-0
Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery
J. Sweeney (2000)
10.1016/S0301-0511(00)00052-1
Aging and measures of processing speed
T. Salthouse (2000)
10.1111/j.1600-0447.2000.tb10944.x
Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors
S. Peretti (2000)
10.1192/bjp.176.5.421
Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression
P. Bech (2000)
10.1016/S0165-0327(99)00092-0
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
I. Anderson (2000)
10.1017/S0033291799001968
Decreased working memory and processing speed mediate cognitive impairment in geriatric depression
R. Nebes (2000)
10.7326/0003-4819-132-9-200005020-00011
A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2
J. Williams (2000)
10.1037/T15072-000
California Verbal Learning Test--Second Edition
D. Delis (2000)
10.1080/026990500413713
Assessing subtle memory impairments in the everyday memory performance of brain injured people: exploring the potential of the extended Rivermead Behavioural Memory Test.
P. Wills (2000)
10.1176/APPI.AJP.157.12.1949
Changes in cognitive functioning following treatment of late-life depression.
M. Butters (2000)
10.1016/S0193-953X(05)70193-3
Cellular mechanisms in the vulnerability to depression and response to antidepressants.
R. Shelton (2000)
Conner’s Continuous Performance Test (CPT II) computer programs for Windows: Technical manual and software guide (Ver
C. K. Conners (2000)
The unity and diversity of executive
T. D. Wager (2000)
Changes in cognitive
B. G. Pollock (2000)
Conner’s Continuous Performance Test (CPT II) computer programs for Windows: Technical manual and software guide (Ver
C. K. Conners (2000)
10.1192/bjp.178.3.200
Cognitive deficits in depression: Possible implications for functional neuropathology
M. Austin (2001)
10.1176/APPI.PSY.42.1.48
Cognitive improvement with treatment of depression following mild traumatic brain injury.
J. Fann (2001)
10.1076/jcen.23.1.121.1223
The Role of Functional Neuroimaging in the Neuropsychology of Depression
M. Liotti (2001)
10.2190/KQ48-XT0L-2H14-5UMV
Fluoxetine's Effects on Cognitive Performance in Patients with Traumatic Brain Injury
Stefanie A Horsfield (2002)
Mechanism of Actions of Antidepressants: Beyond the Receptors
A. Yıldız (2002)
10.1177/026988110201600303
Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man
J. Schmitt (2002)
10.1586/14737175.2.6.849
SNRIs: mechanism of action and clinical features
O. Lambert (2002)
10.1093/BRAIN/AWF049
Decision-making processes following damage to the prefrontal cortex.
F. Manes (2002)
10.1016/S0361-9230(01)00780-8
The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression
Y. Levkovitz (2002)
Fluoxetine's effects on
J. Mastropaolo (2002)
Decision-making processes following damage
T. Robbins (2002)
Additional dopamine reup
E. F. Vuurman (2002)
10.1136/bmj.326.7379.1
Breast self examination
J. Austoker (2003)
10.1136/bmj.326.7397.1014
Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis
S. Macgillivray (2003)
10.1093/GERONA/58.12.M1137
Does antidepressant therapy improve cognition in elderly depressed patients?
P. Doraiswamy (2003)
10.1007/s00213-003-1686-5
Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial
J. Deakin (2003)
10.1126/SCIENCE.1083328
Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
L. Santarelli (2003)
10.1097/00004714-200304000-00008
Clinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression
T. Nickel (2003)
10.1002/GPS.802
Sertraline treatment of elderly patients with depression and cognitive impairment
D. Devanand (2003)
10.1192/bjp.182.3.214
Neurocognitive impairment in drug-free patients with major depressive disorder
R. Porter (2003)
10.1017/S0033291703007682
Neuropsychological performance of OCD patients before and after treatment with fluoxetine: evidence for persistent cognitive deficits
M. Nielen (2003)
10.1136/bmj.327.7414.557
Measuring inconsistency in meta-analyses
J. Higgins (2003)
10.1016/j.psychres.2003.09.003
Cognitive deficits are associated with functional impairment in severely depressed patients
W. McCall (2003)
10.1517/14740338.2.4.367
Safety of antidepressants in the elderly
B. Sommer (2003)
10.1016/S0006-3223(02)01674-8
Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression
D. Barch (2003)
10.1016/S0006-3223(03)00231-2
Diagnosis and definition of treatment-resistant depression
M. Fava (2003)
Cognitive deficits are associated
W. V. McCall (2003)
Sertraline treatment of elderly
Y. Stern (2003)
10.1002/14651858.CD003012.PUB2
Active placebos versus antidepressants for depression.
J. Moncrieff (2004)
10.1016/J.JPSYCHIRES.2004.03.003
Executive functions and updating of the contents of working memory in unipolar depression.
P. O. Harvey (2004)
10.1097/00019442-200409000-00007
Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS).
C. Munro (2004)
10.1016/j.biopsych.2004.04.002
Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment
M. Vythilingam (2004)
10.1023/B:NERV.0000009483.91468.fb
The Ecological Validity of Neuropsychological Tests: A Review of the Literature on Everyday Cognitive Skills
N. Chaytor (2004)
10.1097/00019442-200401000-00007
Longitudinal association of initiation/perseveration and severity of geriatric depression.
C. Murphy (2004)
10.1016/J.ACN.2003.09.009
Speed and memory in the WAIS-III Digit Symbol--Coding subtest across the adult lifespan.
S. Joy (2004)
10.2174/0929867043364810
Monoamine oxidases: certainties and uncertainties.
K. F. Tipton (2004)
10.1037/0882-7974.19.1.211
Adult age and digit symbol substitution performance: a meta-analysis.
W. Hoyer (2004)
10.1017/S0033291703008559
Cognitive functions in depressive disorders: evidence from a population-based study
E. Airaksinen (2004)
Executive functions and updating of the contents
(2004)
Active placebos versus
J. Moncrieff (2004)
10.1016/j.neuroimage.2004.12.023
Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer
I. Loubinoux (2005)
10.1002/HUP.725
SSRIs and cognitive performance in a working sample
E. Wadsworth (2005)
10.1002/hbm.20131
N‐back working memory paradigm: A meta‐analysis of normative functional neuroimaging studies
A. Owen (2005)
10.1016/J.JAD.2005.09.006
Attention and executive functions in remitted major depression patients.
Y. Paelecke-Habermann (2005)
10.1002/HUP.668
Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury
H. Lee (2005)
10.1002/mds.20508
Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression
Paulo S. Boggio (2005)
Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson ' s disease and concurrent depression
M. Borenstein (2005)
10.1002/ana.20817
A longitudinal functional magnetic resonance imaging study of language development in children 5 to 11 years old
Jerzy P. Szaflarski (2006)
10.1016/J.JAD.2005.11.003
Pattern of impaired working memory during major depression.
E. J. Rose (2006)
10.1016/J.JAD.2006.01.018
Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy.
R. Gallassi (2006)
10.1097/01.jcp.0000227699.26375.f8
Mood and Neuropsychological Changes in Women With Midlife Depression Treated With Escitalopram
T. Wroolie (2006)
10.1016/j.biopsych.2005.09.019
Cognitive Function in Late Life Depression: Relationships to Depression Severity, Cerebrovascular Risk Factors and Processing Speed
Y. Sheline (2006)
10.3949/CCJM.73.4.351
Side effects of antidepressants: an overview.
Elias A. Khawam (2006)
10.1016/j.psychres.2005.11.011
Neurocognitive deficits and disability in major depressive disorder
J. Jaeger (2006)
Pattern of impaired working memory
E. S0033291713002535. Rose (2006)
10.1001/ARCHPSYC.64.5.532
Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia.
D. Dickinson (2007)
10.1177/0891988707308803
Neurocognitive Costs and Benefits of Psychotropic Medications in Older Adults
J. Brooks (2007)
10.1097/JCP.0b013e31802e0002
Does Fluoxetine Have Any Effect on the Cognition of Patients With Mild Cognitive Impairment?: A Double-Blind, Placebo-Controlled, Clinical Trial
A. Mowla (2007)
10.1002/PDS.1385
Reasons for antidepressant prescriptions in Canada
S. Patten (2007)
10.1093/AJE/KWP016
Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.
I. Shrier (2007)
10.1097/jcp.0b013e31814b98c1
Does Serotonin Augmentation Have Any Effect on Cognition and Activities of Daily Living in Alzheimer's Dementia?: A Double-Blind, Placebo-Controlled Clinical Trial
A. Mowla (2007)
10.1176/AJP.2007.164.6.900
Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
J. Raskin (2007)
10.1016/j.biopsych.2006.12.022
A Longitudinal Functional Magnetic Resonance Imaging Study of Verbal Working Memory in Depression After Antidepressant Therapy
N. Walsh (2007)
10.1186/1471-244X-7-32
Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study
S. Naismith (2007)
10.1016/j.eurpsy.2006.11.004
Computerized assessment of cognition in schizophrenia: Promises and pitfalls of CANTAB
Marie-Noëlle Levaux (2007)
Neurocognitive costs and benefits
J. O. Brooks (2007)
Does fluoxetine
A. Mowla (2007)
10.1371/journal.pmed.0050045
Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration
I. Kirsch (2008)
10.1111/j.1399-5618.2008.00639.x
Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
S. N. Ghaemi (2008)
10.31887/dcns.2008.10.3/mabutters
Pathways linking late-life depression to persistent cognitive impairment and dementia
M. Butters (2008)
10.1111/j.1600-0447.2008.01285.x
Mediators of the association between depression and role functioning
M. A. Buist-Bouwman (2008)
Mediators of the association
E. Sonderen (2008)
10.2174/157340009788971137
A Review of Modern Antidepressants' Effects on Neurocognitive Function
E. Biringer (2009)
Neuropsychological functioning in patients with posttraumatic stress disorder following short-term paroxetine treatment.
N. Fani (2009)
10.1192/bjp.bp.108.051193
Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action
C. Harmer (2009)
10.1517/14728210903107751
Emerging drugs for major depressive disorder
S. Kennedy (2009)
10.1136/bmj.b3128
Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study
B. Tendal (2009)
10.1002/9780470743386
Introduction to Meta-Analysis
M. Borenstein (2009)
10.1016/j.jad.2009.04.022
A meta-analysis of depression severity and cognitive function.
Lisa McDermott (2009)
10.1001/archgenpsychiatry.2009.81
National patterns in antidepressant medication treatment.
M. Olfson (2009)
10.1037/t15149-000
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
C. Randolph (2009)
10.1007/s10202-008-0060-4
Antidepressants for neuroenhancement in healthy individuals: a systematic review
Dimitris Repantis (2009)
A review of modern anti
E. Biringer (2009)
PsychCorp. (2009).Wechsler Memory Scale – Fourth Edition (WMS-IV
Antonio Pearson (2009)
A meta-analysis of depres
L. M. McDermott (2009)
10.1097/HTR.0b013e3181d6c715
Impact of Early Administration of Sertraline on Cognitive and Behavioral Recovery in the First Year After Moderate to Severe Traumatic Brain Injury
J. Baños (2010)
10.2478/v10039-010-0053-0
Auditory-verbal declarative and operating memory among patients suffering from depressive disorders - preliminary study.
M. Talarowska (2010)
10.1037/a0017336
Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis.
S. McClintock (2010)
10.1016/j.psychres.2010.03.006
Effects of selective serotonin reuptake and dual serotonergic–noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder
I. Herrera-Guzmán (2010)
10.4103/0019-5545.74318
How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy
C. Andrade (2010)
10.1001/archgenpsychiatry.2009.185
Escitalopram and enhancement of cognitive recovery following stroke.
R. Jorge (2010)
10.1016/j.cpr.2010.03.006
A meta-analysis of the effects of psychotherapy with sexually abused children and adolescents.
S. Harvey (2010)
10.1002/jrsm.12
A basic introduction to fixed-effect and random-effects models for meta-analysis.
M. Borenstein (2010)
10.1016/j.neuroimage.2009.09.008
Functional neural correlates of fluid and crystallized analogizing
J. Geake (2010)
from COMPENDIUM 肺葉捻転
John C. Gicking (2010)
Auditory-verbal declarative and operating
P. Gałecki (2010)
Evidence of absence: A guide to cognitive assessment in Australia
S. Crowe (2010)
10.1517/14728214.2012.660146
Emerging drugs for major depressive disorder
K. R. Connolly (2012)
10.1037/a0028141
Parsing trait and state effects of depression severity on neurocognition: Evidence from a 26-year longitudinal study.
C. Sarapas (2012)
10.1097/PSY.0b013e31825b9855
The Effect of Duloxetine Treatment on Cognition in Patients With Fibromyalgia
R. Mohs (2012)
10.1037/a0025594
Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers.
R. Ashare (2012)
10.1097/YIC.0b013e3283542457
A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
C. Katona (2012)
10.1177/2045125312445469
The drugs don’t work? antidepressants and the current and future pharmacological management of depression
E. Penn (2012)
10.1002/gps.2783
Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline
Michelle E Culang-Reinlieb (2012)
10.1007/978-1-4614-5269-0_8
Measures of Expressive Language
D. Morere (2012)
10.1016/j.drugalcdep.2011.08.015
Neuropsychological deficits associated with cannabis use in young adults.
J. Grant (2012)
Neuropsychological assessment, 5th ed.
M. Lezak (2012)
The effect of duloxetine treatment
M. M. Wohlreich (2012)
10.1093/ACREFORE/9780199975839.013.104
Diagnostic and Statistical Manual of Mental Disorders
J. Williams (2013)
10.1371/journal.pone.0085035
Using Multiple Types of Studies in Systematic Reviews of Health Care Interventions – A Systematic Review
F. Peinemann (2013)
10.1002/sim.5766
Interpreting meta-regression: application to recent controversies in antidepressants' efficacy.
E. Petkova (2013)
10.1016/j.neuropharm.2012.06.064
Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users
A. Kalechstein (2013)
10.1017/S0033291713002535
Cognitive impairment in depression: a systematic review and meta-analysis
P. Rock (2013)
Change in cognitive functioning following acute antidepressant treatment in late-life depression
Michelle E Reinlieb (2013)
10.1016/j.pharmthera.2012.09.006
Serotonin receptors involved in antidepressant effects.
F. Artigas (2013)
10.1002/da.22063
COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONS
R. McIntyre (2013)
10.1017/S0033291713000640
Rapid visual information processing as a cognitive endophenotype of attention deficit hyperactivity disorder
S. Gau (2013)
Cognitive deficits
L. A. Gallaugher (2013)
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
M. J. Carter (2014)
A meta-analysis of effects of
P. Lancaster (2014)
10.1017/S1461145714000546
A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults
R. McIntyre (2014)
10.4088/JCP.13r08609
Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review.
R. Keefe (2014)
10.1002/9781118660584.ESE0399
California Verbal Learning Test, Second Edition
R. Dumont (2014)
10.1155/2014/627863
Does Duloxetine Improve Cognitive Function Independently of Its Antidepressant Effect in Patients with Major Depressive Disorder and Subjective Reports of Cognitive Dysfunction?
T. Greer (2014)
10.1016/j.psychres.2014.05.013
Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression – A systematic review
B. Baune (2014)
Pharmacological and non
B. T. Baune (2014)
10.1146/annurev-clinpsy-032814-112828
Depression and cognition in the elderly.
S. Wang (2015)
10.1016/j.ejphar.2014.07.046
Faster, better, stronger: towards new antidepressant therapeutic strategies.
O. O’Leary (2015)
10.1212/WNL.0000000000001763
Improving clinical cognitive testing
K. Daffner (2015)
10.1007/s00213-015-4172-y
Altered cognitive response to serotonin challenge as a candidate endophenotype for obsessive-compulsive disorder
C. Lochner (2015)
10.1186/s13643-015-0133-0
Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities
C. Cameron (2015)
10.1093/ijnp/pyv082
The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
J. Rosenblat (2015)
10.1016/j.ejphar.2014.07.044
Treatment of cognitive dysfunction in major depressive disorder--a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine.
A. Pehrson (2015)
10.1038/npp.2015.52
A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
A. Mahableshwarkar (2015)
10.1007/978-3-319-33967-2_22
Safety and Tolerability
A. Brunoni (2016)
10.1186/s12874-016-0136-0
Meta-analyses including non-randomized studies of therapeutic interventions: a methodological review
Timor Faber (2016)
10.1016/S2215-0366(16)30067-0
Selection of cognitive tests for trials of therapeutic agents.
J. Harrison (2016)
10.4103/0019-5049.190628
A brief overview of systematic reviews and meta-analyses
K. Sriganesh (2016)
10.1177/0269881116681399
Low doses of mirtazapine or quetiapine for transient insomnia: A randomised, double-blind, cross-over, placebo-controlled trial
J. Karsten (2017)
10.1090/fim/023/04
早期関節リウマチ：brief overview
寛 大岩 (2018)
10.4135/9781412950589.n265
Ecological Validity
Martyn Shuttleworth (2019)
10.1186/s12888-019-2197-1
Subjective experiences of neurocognitive functioning in young people with major depression
Catherine Morey-Nase (2019)
10.31887/DCNS.2019.21.3/trobbins
Pharmacological treatment of cognitive deficits in nondementing mental health disorders

T. Robbins (2019)
10.1007/s11065-019-09415-6
A Guide to Conducting a Meta-Analysis with Non-Independent Effect Sizes
M. Cheung (2019)



This paper is referenced by
10.1177/0253717620981556
Geriatric Depression and Cognitive Impairment—An Update
S. Mukku (2021)
10.2147/NDT.S307119
The Effects of Repetitive Transcranial Magnetic Stimulation Antidepressant Response on Cold Cognition: A Single-Arm Prospective Longitudinal Study
H. Hopman (2021)
NDT_A_315572 2315..2325
Chia-Yu Huang (2021)
10.1080/13803395.2021.1894094
Executive functioning in psychiatric patients with deliberate self-harm, as compared with a psychiatric and a healthy comparison group
M. Nilsson (2021)
10.1016/j.neubiorev.2021.02.038
Pharmacological enhancing agents targeting cognition in patients with alcohol-induced neurocognitive disorders: A systematic review
Nicolaj Mistarz (2021)
10.1007/s00115-021-01074-4
Kognitive Störungen bei Patienten mit Depression
Thomas M. Schilling (2021)
10.1159/000513270
Assessing Pragmatic Language Skills in Adults with Major Depressive Disorder: An Exploratory Study
Maria Clelia Zurlo (2021)
10.3390/brainsci11060771
Impact of Depression and Anxiety on Dimensions of Health-Related Quality of Life in Subjects with Parkinson’s Disease Enrolled in an Association of Patients
Fany Chuquilín-Arista (2021)
10.2147/NDT.S315572
Acupuncture Treatment Reduced the Risk of Coronary Heart Disease in Patients with Depression: A Propensity-Score Matched Cohort Study
Chia-Yu Huang (2021)
10.1101/2021.03.23.21254003
Computerized Cognitive Training in People with Depression: A Systematic Review and Meta-analysis of Randomized Clinical Trials
N. H. Launder (2021)
10.1002/gps.5402
Executive functioning of older adults with bipolar disorder
Elad Omer (2021)
10.1080/13825585.2020.1840505
Weak associations between depressive symptom severity, depressive symptom clusters, and cognitive performance in young to middle-aged men without clinical depression.
S. Szymkowicz (2020)
10.1016/j.jad.2020.01.068
Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control.
Juliana Corlier (2020)
10.1016/j.neuropharm.2020.108118
Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease
Alok Joshi (2020)
10.1016/j.yebeh.2020.107359
A prospective pilot study of cognitive impairment and mood in adults with first seizure, new-onset epilepsy, and newly diagnosed epilepsy at time of initial seizure presentation
Caitlin S Jackson-Tarlton (2020)
10.1080/00207454.2019.1711078
A novel stress re-stress model: modification of re-stressor cue induces long-lasting post-traumatic stress disorder-like symptoms in rats
S. Prajapati (2020)
10.1186/s13643-020-01320-x
Cognitive interventions for adults with chronic kidney disease: protocol for a scoping review
J. Farragher (2020)
10.1017/S0033291720002871
Executive deficits in schizophrenia: mediation by processing speed and its relationships with aging.
Flavien Thuaire (2020)
10.31363/2313-7053-2020-4-82-93
Contemporary approaches to correction of cognitive impairment in endogenous depression
I. V. Oleichik (2020)
10.1080/13651501.2020.1836225
Psychological pain and depression: it’s hard to speak when it hurts
S. Richard-Devantoy (2020)
10.1080/23279095.2020.1726919
A pilot study of cognitive remediation in remitted major depressive disorder patients.
Åsa Hammar (2020)
10.1016/j.jad.2020.07.114
Sex differences in the cognitive function of first-diagnosed, drug-naïve depressed patients: An observational case-control study.
L. Wang (2020)
10.3390/nu12123630
Verbal Memory Performance in Depressed Children and Adolescents: Associations with EPA but Not DHA and Depression Severity
Sophie Emery (2020)
10.1016/j.schres.2020.03.008
Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial
S. Mallawaarachchi (2020)
10.3389/fpsyt.2020.00118
Social Cognition and Obsessive-Compulsive Disorder: A Review of Subdomains of Social Functioning
M. Jansen (2020)
10.21203/rs.3.rs-66217/v1
Computerized Cognitive Training in People with Depression: A Protocol for a Systematic Review and Meta-Analysis
A. Lampit (2020)
10.1101/2020.02.06.934752
Identifying Nootropic Drug Targets via Large-Scale Cognitive GWAS and Transcriptomics
M. Lam (2020)
10.1007/s11065-020-09436-6
Depression and Cognitive Control across the Lifespan: a Systematic Review and Meta-Analysis
V. Dotson (2020)
10.1016/j.jep.2020.112830
Potential effect of herbal antidepressants on cognitive deficit: Pharmacological activity and possible molecular mechanism.
Jianmei Li (2020)
10.1007/s41999-020-00349-4
The association between antidepressants use and development of cognitive impairment among older women diagnosed with breast cancer
Yasser Alatawi (2020)
10.1007/978-3-030-04266-0_7
Cognitive Dysfunction in the Workplace: Focus on Depression
R. Lam (2019)
10.1186/s12888-019-2197-1
Subjective experiences of neurocognitive functioning in young people with major depression
Catherine Morey-Nase (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar